& Introduction: It was to be examined whether EEG monitoring infl uences the dosing practice of propofol, taking into account age, gender, mode of propofol administration, and opioid choice. Methods: At 32 study sites, 3 542 patients received total intravenous anaesthesia (TIVA) or target-controlled infusion (TCI). 472 anaesthetics were controlled by clinical parameters (blinded EEG recordings), in 3 070 anaesthetics, the EEG was used for the control of anaesthesia (EEG monitor Narcotrend ® , EEG classifi cation into the stages A (awake) to F (very deep anaesthesia)). Results: Without EEG monitoring, 5.9 % of the anaesthetics were maintained in stage B / C (increased risk of awareness), in 18.7 % a burst suppression EEG was found (individual overdosage of general anaesthesia, stage F). 67.2 % were conducted in stages D / E, which correspond to deep sleep. EEG monitoring resulted in changes of the propofol dosage from − 28.4 % to + 86.2 % . In EEG controlled anaesthetics, women received more propofol than men and had shorter recovery times. Furthermore, with increasing age, a larger reduction of the propofol dosages was found than without EEG, and the diff erence between the propofol dosages of both genders became smaller with increasing age. Compared to fentanyl, the use of the short-acting opioid remifentanil led to a signifi cant reduction in propofol requirements and recovery times. EEG monitoring caused a signifi cant reduction in propofol consumption with TCI. Discussion: A considerable number of the anaesthetics which were controlled solely by clinical parameters was too light or too deep. EEG monitoring resulted in signifi cant changes in the dosing strategies at the study sites. Conclusion: EEG monitoring helps to determine the individual requirements for propofol, which depend on gender, age, and opioid choice.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
hi@scite.ai
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.